ROR1 is known to activate signaling pathways through phosphorylation in cancers such as chronic lymphocytic leukemia (CLL) and ovarian cancer, including downstream JAK/STAT effector proteins [45,46]. Here, SOAT1 is linked to ovarian cancer.